MedTrace Logo

PMCF Study of LiquiBand FIX8® OHMF Device

NCT04059640 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2025-10-02

No results posted yet for this study

Summary

Study to evaluate the safety and performance of LiquiBand FIX8® Open Hernia Mesh Fixation Device.

Conditions

  • Inguinal Hernia

Interventions

DEVICE

LiquiBand FIX8 Open Hernia Mesh Fixation Device

Subjects will undergo hernia mesh fixation and topical wound closure using the LiquiBand FIX8® OHMF device. Subjects will be evaluated intra-operatively, post-operatively, at discharge, and at 12 months post-operatively. The Liquiband surgical study device is considered a permanent implant.

Sponsors & Collaborators

  • Imarc Research, Inc.

    collaborator INDUSTRY

  • Advanced Medical Solutions Ltd.

    lead INDUSTRY

Principal Investigators

  • Andrei Mihailescu, MD · Tameside & Glossop Integrated Care NHS Foundation Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-07
Primary Completion
2025-07-31
Completion
2026-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04059640 on ClinicalTrials.gov